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ABSTRACT: Synthetic polymers containing quaternary phosphonium salts are an emerging class 
of materials for the delivery of oligo/polynucleotides. In this work, cationic phosphonium salt-
containing polymethacrylates –and their corresponding ammonium analogues– were synthesized 
by RAFT polymerization. Both the nature of the charged heteroatom (N vs. P) and the length of 
the spacer separating the cationic units along the polymer backbone (oxyethylene vs. 
trioxyethylene) were systematically varied. Polymers efficiently bound siRNA at N+/P- or P+/P- 
ratios of 2 and above. At a 20:1 ratio, small polyplexes (Rh: 4-15 nm) suitable for cellular uptake 
were formed that displayed low cytotoxicity. Whilst siRNA polyplexes from both ammonium and 
phosphonium polymers were efficiently internalised by GFP-expressing 3T3 cells, no knockdown 
of GFP expression was observed. However, 65% Survivin gene knockdown was observed when 
short interfering RNA (siRNA) was replaced with novel, multimerised long interfering liRNA 
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(liRNA) in HeLa cells, demonstrating the importance of RNA macromolecular architecture on 
RNA-mediated gene silencing.  
 
INTRODUCTION 
Over the past few years RNA interference (RNAi) mediated by double stranded RNA has gained 
enormous attention as a potential therapeutic strategy to treat currently undruggable diseases1–3. 
However, the delivery of RNA to the desired target organ as well as the control over intracellular 
trafficking remains a major challenge currently limiting the technology. Various strategies for 
RNA delivery have been explored, such as the application of lipid-based delivery systems 
(lipoplexes and liposomes)4–6, nanoparticles7–9, viruses10, peptide-based systems7, polymers11–14 
and gold-based materials15–18.  
Polymer-based delivery systems offer the potential advantages of scalability, increased safety 
and flexibility to introduce modifications post polymerization for targeted delivery19.  Recent 
advances in controlled radical polymerization (CRP) provide unprecedented control over 
monomer sequence20,21, chemical functionalities22,23 and molecular weight distribution24–26. CRP 
has been extensively utilized for the synthesis of polymers suitable for biological applications such 
as nucleic acid delivery systems25,27–34. Covalent and non-covalent RNA-polymer conjugation 
approaches have been described35. The latter strategy, where polymer-nucleic acid complexes 
(polyplexes) are generated via ionic interactions between cationic polymers and negatively 
charged RNA has been more frequently investigated. Whilst nitrogen-containing cationic 
polymers such as N,N-dimethylaminoethyl methacrylate (DMAEMA), polyethylenimine (PEI), 
poly(l-lysine) and others are commonly used36,37,  polymers incorporating phosphonium salt 
functionalities have recently started to gain interest as novel materials with a range of properties 
complementing existing nitrogen-based systems38–44. Phosphonium-containing polymers have 
been engineered with reduced cytotoxicity and efficient binding of oligonucleotides, at least in 
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part due to the different ionic radius and charge distribution of quaternary phosphonium salts 
compared to their corresponding ammonium counterparts38–40. However, the application of 
phosphonium polymers in oligo/polynucleotide delivery is to date still limited, with only few 
phosphonium based monomers readily available. A significant challenge in this has been the 
identification of appropriate synthetic routes, additional cost of starting materials, and air-sensitive 
and often pyrophoric nature of the organic phosphine precursors required for their preparation. 
In the present study we report a novel synthetic route for a new class of cationic 
polymethacrylates. This involved the synthesis of water soluble, phosphonium containing 
methacrylate monomers – and their corresponding ammonium analogues - and subsequent aqueous 
RAFT polymerization. The resulting methacrylate polymers were characterized with regards to 
their physicochemical properties and suitability as RNA delivery systems. The influence of 
polymer structural parameters such as the nature of the charged heteroatom (N vs P) and the length 
of the spacer connecting the later to the polymer backbone were investigated. In addition, the 
impact on gene knockdown of the molecular architecture of RNA was evaluated. 
  
EXPERIMENTAL SECTION 
Materials: Chemicals and reagents were purchased at the highest purity available from Sigma-
Aldrich unless otherwise stated and were used as received without purification. All solvents were 
bought from Fisher Scientific. Yields of monomers and intermediates were not optimized. Cell 
reagents were purchased from Life Technologies, unless stated otherwise. siRNA duplexes for gel 
retardation assays and GFP knockdown studies were purchased from Dharmacon (siGENOME 
Non-Targeting siRNA #2 and GFP Duplex I, P-002048-01); siRNA for cellular uptake studies was 
purchased from Qiagen (AllStars negative siRNA Alexa Fluor 647). liRNA containing the 
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following sequence: 5' UGAAAAUGUUGAUCUCCUUUCCUAAGACAUUGCUAAGG 3' and 
3' AGGAUUCUGUAACGAUUCCACUUUUACAACUAGAGGAA 5' was purchased from ST 
Pharm (Seoul, Korea) and multimerized. Interferin was obtained from Polyplus transfection. 
Primers for reverse transcriptase PCR were purchased from Daejeon (Korea): GAPDH forward
 5’ GACTCAACGGATTTG GTC GT 3’, GAPDH reverse 
5’GACAAGCTTCCCGTTCTCAG 3’, Survivin forward 5’GCACCACTTCCAGGGTTTAT 3’, 
Survivin reverse 5’ CTCTGGTGCCACTTTCAAGA 3’;  
Analysis: Mass spectrometry (MS) was performed using a Waters 2795 separation 
module/micromass LCT platform. Samples were mixed with 200 µl of acetonitrile + 0.1% formic 
acid and 200 µl of water + 0.1% formic acid and analyzed immediately. 
Nuclear magnetic resonance (NMR) spectra were acquired with a Bruker DPX UltraShield 
spectrometer at 25°C. Samples (1H NMR, 13C NMR, 31P NMR) were prepared in deuterated 
solvents (CDCl3, D2O or DMSO-d6, Methanol-d4) and chemical shifts were reported in parts per 
million (ppm) with reference to solvent residual peaks or tetramethylsilane (TMS). Coupling 
constants were reported in Hertz (Hz). Spectra were collected following frequencies: 400 MHz 
(1H), 100 MHz (13C) and 161.9 MHz (31P). Spectra were processed using Mestrenova software 
6.0.2. Fourier transform infrared spectroscopy (FT-IR) was performed with an Agilent Cary 630 
FTIR spectrometer.  
 
N,N,N-triethyl-2-(methacryloyloxy)ethan-1-aminium chloride (3a): Monomer 3a was 
prepared in a 2 step reaction process. Firstly, 2-bromoethanol (35.3 g, 280 mmol) and Et3N (42.8 
g, 423 mmol) in toluene (100 ml) were heated at 75°C for 48 hours under continuous stirring. The 
white, semi-crystalline precipitate (2a) was filtered, washed with toluene, and dried in a desiccator 
under reduced pressure overnight (yield: 34.2 g, 54%). The intermediate 2a (33.0 g, 146 mmol) 
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and Et3N (24.3 g, 240 mmol) in CH2Cl2 (100 ml) were cooled to 0°C and a solution of methacryloyl 
chloride (18.8 g, 180 mmol) in CH2Cl2 (50 ml) was added dropwise over a period of 30 minutes. 
The reaction was stirred for 30 minutes at 0°C, then at ambient temperature for 18 hours. Following 
quantitative conversion of 2a into 3a, which was confirmed by 1H NMR, the reaction was cooled 
to 0°C and the excess of methacryloyl chloride quenched with MeOH (20 ml). The product (3a) 
was then precipitated in ice-cold Et2O for a minimum of 3 times. The residue was dissolved in 
dH2O (300 ml) and transferred into a separation funnel. A solution of Na2CO3 (1.5×mol 
methacryloyl chloride, ~30 ml) was added to the separation funnel to deprotonate triethylamine 
hydrochloride and the aqueous layer was then washed with petroleum ether (2×200 ml) to remove 
any non-polar organic compounds. To exchange the counter ion, solid NaCl was added portion 
wise until saturation was reached (~60-100 g). The excess salt was filtered into a Buchner filter 
and the aqueous phase was then extracted with CHCl3:2-propanol (3:1 vol/vol) for 4 times. The 
organic layers were combined, the solvent evaporated under reduced pressure, and residue purified 
by flash chromatography (EtOAc: MeOH gradient from 3:1 to 6:4 vol/vol). Following 
chromatography, the fractions containing the monomer (3a) were combined and the solvent 
removed under reduced pressure. The resulting residue was solubilised in THF and filtered to 
remove residual insoluble triethylammoniun hydrochloride which was still present in the product. 
The solvent was then removed under reduce to afford monomer (3a) as a white solid which was 
stored at 4°C (yield: 6.7 g, 21%). 
2a: C8H20BrNO, FW: 226.15 g mol
-1; 1H NMR (400 MHz, D2O) δH 3.99 (t, J=5.2 Hz, 2H, 
HOCH2), 3.44 – 3.34 (m, 8H, CH2N+(CH2CH3)3), 1.29 (t, J=7.2 Hz, 9H, CH2N+(CH2CH3)3). 13C 
NMR (101 MHz, D2O) δC 57.4, 54.8, 53.4, 6.8. Mass Spectrometry: expected m/z: 146.15 [M+], 
found 146.06 [M+]. FT-IR (neat): ν = 3216 (OH), 2981 (CH), 2944 (CH), 1628 (CC) cm-1.  
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3a: C12H24ClNO2, FW: 249.78 g mol
-1; 1H NMR: δH (400 MHz, CDCl3) 6.09 – 6.05 (m, 1H, 
CH), 5.64 – 5.60 (m, 1H, CH), 4.63 – 4.58 (m, 2H, C(O)OCH2), 3.89 – 3.84 (m, 2H, OCH2CH2), 
3.55 (q, J =7.3 Hz, 6H, (+N(CH2CH3)3), 1.91 – 1.87 (m, 3H, CH3), 1.42 – 1.35 (m, 9H, 
(+N(CH2CH3)3). 
13C NMR: δC (101 MHz, CDCl3) 166.3, 135.0, 127.3, 57.8, 55.8, 54.3, 18.3, 8.2. 
Mass Spectrometry: expected m/z: [M+] 214, found 214 [M+]. FT-IR (neat): v= 2984 (CH), 2924 
(CH), 1719 (CO), 1636 (CC) cm-1.  
 
Triethyl(2-(methacryloyloxy)ethyl)phosphonium chloride (3b): 2-Bromoethanol (13.8 g, 
111 mmol) was dissolved in THF (100 ml) and the resulting solution was carefully deoxygenated 
by nitrogen bubbling for 30 min.  A 1.0 M solution of Et3P in THF (50 mL 5.9 g, 50 mmol) was 
then added under inert atmosphere (CAUTION: Et3P is spontaneously flammable in air, and must 
be handled under inert atmosphere). The reaction mixture was stirred at 50°C for 48 hours. The 
reaction mixture was cooled down to room temperature, the supernatant was then decanted off and 
discarded, while the white precipitate at the bottom was re-solubilised in methanol (~30 ml) and 
precipitated in Et2O (~600 ml). This procedure was repeated until a white solid product (2b) was 
obtained. The latter was filtered, washed with toluene and dried under reduced pressure overnight 
(yield: 17.5 g, 65%). The intermediate (2b) (17.5 g, 72 mmol) and Et3N (14.6 g, 144 mmol) in 
CH2Cl2 (100 ml) were cooled to 0°C and a solution of methacryloyl chloride (11.3 g, 108 mmol) 
in CH2Cl2 (50 ml) was added dropwise. The reaction was stirred for 30 minutes on ice, followed 
by further 18 hours at ambient temperature. The reaction mixture was cooled to 0°C and the excess 
of methacryloyl chloride quenched with MeOH (50 ml). The final product (3b) was extracted using 
the same protocol described for monomer 3a. The monomer was stored at 4°C (yield: 5.0 g, 26%). 
 7 
2b: C8H20BrPO, FW: 243.12 g mol
-1; 1H NMR: δH (400 MHz, CDCl3) 4.15 (dt, J = 20.9, 5.8 Hz, 
2H, HOCH2), 2.68 (dt, J = 11.7, 5.8 Hz, 2H, CH2CH2P
+), 2.48 (dq, J = 13.0, 7.7 Hz, 6H, 
CH2P
+(CH2CH3)3), 1.35 (dt, J = 18.2, 7.7 Hz, 9H, CH2P
+(CH2CH3)3). 13C NMR: δC (101 MHz, 
CDCl3) 54.7 (d, J = 7.3 Hz), 21.9 (d, J = 49.3 Hz), 13.0 (d, J = 48.6 Hz), 6.0 (d, J=5.5 Hz). 
31P 
NMR: δP (162 MHz, CDCl3) 38.85 (+P(CH2CH3)3). Mass Spectrometry: m/z: [M+] 164.12 [M+], 
found 164.01 [M+]. FT- IR (neat): v= 3353 (OH), 2944 (CH), 2892 (CH), 1640 (CC) cm-1.  
 
3b: C12H24ClO2P, FW: 266.74 g mol
-1; 1H NMR: δH (400 MHz, CDCl3) 6.12 – 6.08 (m, 1H, 
CH), 5.69 – 5.64 (m, 1H, CH), 4.57 (dt, J = 17.6, 6.3 Hz, 2H, C(O)OCH2), 3.07 (dt, J =12.6, 6.3 
Hz, 2H, OCH2CH2), 2.59 (dq, J = 13.0, 7.7 Hz, 6 H, (
+P(CH2CH3)3), 1.93 (m, 3H, CH3), 1.39 – 
1.28 (m, 9H, (+P(CH2CH3)3). 
13C NMR: δC (101 MHz, CDCl3) 166.4, 135.1, 127.2, 57.8 (d, J = 
5.4 Hz), 19.1 (d, J = 48.4 Hz), 18.2, 13.1 (d, J =48.3 Hz), 6.2 (d, J = 5.5 Hz). 31P NMR: δP (162 
MHz, CDCl3) 37.94 (+P(CH2CH3)3). Mass Spectrometry: m/z: [M
+] 231, found 231 [M+]. FT- IR 
(neat): v= 2913 (CH), 2885 (CH), 1715 (CO), 1636 (CC) cm-1.  
 
 
N,N,N-triethyl-2-(2-(2-(methacryloyloxy)ethoxy)ethoxy)ethan-1-aminium chloride (3c): 
Firstly, neat 2-[2-(2-chloroethoxy)ethoxy]ethanol (10 g, 59 mmol) was converted into its 
corresponding bromide by reaction with finely grounded NaBr (18.2 g, 177 mmol) at 70°C for 48 
hours, under nitrogen atmosphere. The reaction was monitored by 13C NMR following the 
reduction of the CH2Cl signal at ~42 ppm and the appearance of a new signal at ~30 ppm for 
CH2Br (1c). The conversion of 2-[2-(2-chloroethoxy)ethoxy]ethanol into its corresponding alkyl 
bromide was not quantitative (conversion was estimated to be ~57% as analyzed by 13C NMR), 
however, this did not interfere with the following step, most likely because the bromide ions 
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generated in situ in that reaction could still facilitate the nucleophilic substitution with P or N 
nucleophiles to give the required ammonium and phosphonium salts.  The product was 
resolubilised in CH2Cl2 (50 ml) and the excess of NaBr salt and formed NaCl were filtered off 
using a Buchner filter.  CH2Cl2 was removed under reduced pressure and the resulting alcohol 
bromide intermediate was used for the following step without further purification. The 
intermediate 2c and neat Et3N were reacted at 75°C for 48 hours, under stirring. The brown bottom 
layer was separated from the yellow top phase, solubilised in MeOH, precipitated in Et2O and 
utilized for the next step without further purification (yield: 11.6 g, 62% based on 2-[2-(2-
chloroethoxy)ethoxy]ethanol utilized for the initial step). The crude intermediate (2c) (11.6 g, 37 
mmol) was dissolved in CH2Cl2 (100 ml) and Et3N (7.5 g, 74 mmol), and the resulting solution 
was cooled to 0°C. A solution of methacryloyl chloride (5.8 g, 56 mmol) in CH2Cl2 (50 ml) was 
added dropwise to the reaction and was stirred for 30 minutes on ice (0°C), then at ambient 
temperature for 18 hours. The completion of the reaction was confirmed by 1H NMR and the 
excess of methacryloyl chloride was quenched in MeOH. The work up, including the conditions 
for flash chromatography on SiO2, was carried out as described for (3a). The monomer was stored 
at 4°C (yield: 5.0 g, 40%). 
2c: C12H28BrNO3, FW: 314.26 g mol
-1; 1H NMR: δH (400 MHz, CDCl3) 4.02 (m, 2H, 
OCH2CH2N
+), 3.84 – 3.49 (m, 16H, HOCH2CH2OCH2CH2OCH2CH2N+(CH2CH3)3, 1.37 (t, J = 
6.9 Hz, 9H, N+(CH2CH3)3). Mass Spectrometry: m/z: 234.21 [M
+], found 234.87 [M+]. FT-IR 
(neat): v= 3318 (OH), 2907 (CH), 2879 (CH), 1640 (CC), 1122 (CO) cm-1.  
 
3c: C16H32ClNO4, FW: 337.88 g mol
-1; 1H NMR: δH (400 MHz, CDCl3) 6.00 (m, 1H, CH), 5.52 
– 5.47 (m, 1H, CH), 4.20 – 4.14 (m, 2H, C(O)OCH2CH2), 3.87 (t, J = 9.0 Hz, 2H, C(O)OCH2CH2), 
3.66 – 3.56 (m, 8H, OCH2CH2OCH2CH2N+), 3.43 (q, J = 7.2 Hz, 6H,  N+(CH2CH3)3), 1.85 – 1.82 
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(m, 3H, CH3), 1.32 – 1.25 (m, 9 H, N+(CH2CH3)3). 13C NMR: δC (101 MHz, CDCl3) 167.1, 135.9, 
125.8, 70.5, 70.2, 69.0, 64.4, 63.6, 57.2, 54.3, 18.2, 8.22. Mass Spectrometry: m/z: [M+] 302, found 
302 [M+]. FT-IR (neat): v= 2980 (CH), 2943 (CH), 1713 (CO), 1635 (CC), 1124 (CO) cm-1.  
 
Triethyl(2-(2-(2-(methacryloyloxy)ethoxy)ethoxy)ethyl)phosphonium chloride (3d): 
Following the partial conversion of 2-[2-(2-chloroethoxy)ethoxy]ethanol (10 g, 59 mmol) into its 
corresponding bromide as described for monomer 3c, the resulting intermediate was dissolved in 
THF (100 ml), the solution was carefully degassed by N2 bubbling, and a 1.0 M solution of Et3P 
in THF (47 mL, 5.5 g, 47 mmol) was added under inert atmosphere (CAUTION: Et3P is 
spontaneously flammable in air, and must be handled under inert atmosphere). The reaction 
solution was then stirred at 50°C for 48 hours. After completion, two phases were observed. The 
desired phosphonium alcohol intermediate 2d was found to be in the bottom phase of the reaction, 
as revealed by 1H and 31P NMR analysis. The top layer was then decanted off and the resulting 
brown residue was desiccated under reduced pressure (yield: 11.1 g, 59%). Next, the intermediate 
2d (11.1 g, 33.5 mmol), Et3N (6.8 g, 67 mmol) were dissolved in  CH2Cl2 (100 ml) and a solution 
of methacryloyl chloride (5.2 g, 50 mmol) in  CH2Cl2 (50 ml) was added at 0°C over the duration 
of 30 minutes period, then stirred at ambient temperature for 18 hours. Completion of the reaction 
was confirmed by 1H NMR and the excess of methacryloyl chloride was quenched with MeOH 
(30 ml) at 0°C. The crude residue was then purified as described for the other monomers. The 
monomer was stored at 4°C (yield: 7.67 g, 64%). 
2d: C12H28BrO3P, FW: 331.23 g mol
-1; 1H NMR: (400 MHz, CDCl3) δH 4.00 – 3.84 (m, 2H, 
HOCH2CH2), 3.78 – 3.49 (m, 10H, HOCH2CH2OCH2CH2OCH2CH2P+), 2.55 – 2.39 (m, 6H, 
+P(CH2CH3)3, 1.29 (m, 9H, +P(CH2CH3)3. 31P NMR: (162 MHz, CDCl3) δP 38.9 (+P(CH2CH3)3. 
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Mass Spectrometry: m/z: 251.33 [M+], found 251.79 [M+]. FT-IR (neat): v= 3433 (OH), 2980 
(CH), 2960 (CH), 1635 (CC), 1124 (CO) cm-1.  
 
3d: C16H32ClO4P, FW: 354.85 g mol
-1; 1H NMR: δH (400 MHz, CDCl3) 6.13 (m, 1H, CH), 5.66 
– 5.61 (m, 1H, CH), 4.30 (t, J = 4.9 Hz, 2H, C(O)OCH2), 3.94 (dt, J = 19.7, 5.9 Hz, 2H, 
OCH2CH2P
+), 3.77 – 3.61 (m, 6H, C(O)OCH2CH2OCH2CH2OCH2CH2P+), 3.04 (dt, J = 12.2, 5.9 
Hz, 2H, OCH2CH2P
+), 2.53 (dq, J = 13.5, 7.7 Hz, 6H, +P(CH2CH3)3), 1.96 (m, 3 H, CH3), 1.31 (dt, 
J = 18.2, 7.7 Hz, 9H, +P(CH2CH3)3. 
13C NMR: δC (101 MHz, CDCl3) 70.2 (s), 70.0 (s), 68.8 (s), 
63.9 (d, J = 7.6 Hz), 63.5 (s), 19.7 (d, J = 49.7 Hz), 18.1 (s), 12.6 (d, J = 48.7 Hz), 5.8 (d, J = 5.5 
Hz). 31P NMR δP (162 MHz, CDCl3) 38.75 (+P(CH2CH3)3). Mass Spectrometry: m/z: [M+] 319, 
found 319 [M+]. FT-IR (neat): v= 2940 (CH), 2888 (CH), 1715 (CO), 1637 (CC), 1112 (CO) cm-
1.  
 
RAFT polymerization of methacrylate polymers (4a-d): General procedure: Monomer (3a-
d), V-501 (initiator) and 4-cyano-4-(thiobenzoylthio)pentanoic acid (CTP, RAFT agent) were 
charged into a Schlenk tube along with D2O:EtOH (3:1 vol/vol, 4 ml). The tube was sealed and 
degassed by four freeze-pump-thaw cycles. The reaction was started by immersing the Schlenk 
tube into an oil bath at 70°C. To monitor the reaction, samples were taken at various time-points 
for molecular weight and conversion analysis. The latter was monitored by 1H NMR spectroscopy, 
following the decrease of the monomer vinyl signals (5.6 and 6.2 ppm) using the ester C(O)OCH2 
signal for monomer and polymer at ~ 4.5 ppm. Once the desired conversion was reached, the 
polymerization was stopped by placing the Schlenk tube in an ice bath and by exposing the reaction 
mixture to air. Polymers were precipitated in ice-cold THF and/or diethyl ether. The polymer CTA 
end-group was removed as described by Perrier and coworkers45,46. Briefly, the polymer was 
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dissolved in DMSO and AIBN was added (polymer: AIBN = 1:20 mol:mol). The reaction mixture 
was deoxygenated for 15 minutes by nitrogen bubbling and then reacted at 80°C for 3 hours. The 
polymers were then precipitated in THF, dried under reduced pressure and stored at 4°C.  
Reaction conditions of RAFT polymerization: [M]0:[CTA]0:[I]0= 100:1:0.5 
Polymer 4a: 3a 1.0 g (4.0 mmol), CTP 11 mg (0.040 mmol), V-501 6.5 mg (0.020 mmol);  
Polymer 4b: 3b 1.0 g (3.75 mmol), CTP 10.4 mg (0.0370 mmol), V-501 6.1 mg (0.019 mmol);  
Polymer 4c: 3c 1.0 g (2.9 mmol), CTP- 7.34 mg (0.0264 mmol), V-501-4.3 mg (0.013 mmol); 
Polymer 4d: 3d 1.0 g (2.8 mmol), CTP- 7.8 mg (0.028 mmol), V-501- 4.5 mg (0.014 mmol);  
 
4a: 1H NMR: δH (400 MHz, D2O) 4.39 (COOCH2), 3.62 (OCH2CH2), 3.36 (+N(CH2CH3)3), 1.93 
(CH2 of polymer backbone), 1.29 (
+N(CH2CH3)3), 1.18 – 0.78 (CH3 of polymer backbone).  
4b: 1H NMR: δH (400 MHz, D2O) 4.28 (COOCH2), 2.68 (OCH2CH2), 2.25(+P(CH2CH3)3), 2.04 
– 1.58 (CH2 of polymer backbone), 1.31 – 1.12 (+P(CH2CH3)3), 0.90 (CH3 of polymer backbone).  
4c: 1H NMR: δH (400 MHz, D2O) 4.11 (C(O)OCH2), 3.86 - 3.67 (CH2OCH2CH2OCH2CH2), 
3.42 – 3.23 (+N(CH2CH3)3), 1.86 (CH2 of polymer backbone), 1.24 ((+N(CH2CH3)3), 0.92 (CH2 of 
polymer backbone).  
4d: 1H NMR: δH (400 MHz, D2O) 4.11 (C(O)OCH2), 3.89 – 3.59 (CH2OCH2CH2OCH2), 2.51 
(CH2P
+), 2.22 (+P(CH2CH3)3), 1.84 (CH2 of polymer backbone), 1.19 (
+P(CH2CH3)3), 0.92 (CH3 
of polymer backbone).  
 
Size exclusion chromatography (SEC): Size exclusion chromatography (SEC) was performed 
on a Polymer Labs GPC50 instrument fitted with a differential refractive index detector. 
Separations were performed on a pair of PLGel Mixed-D columns (300 × 7.5 mm) fitted with a 
matching guard column (50 × 7.5 mm). The mobile phase was 0.5% NH4BF4 (w/v) in N,N-
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dimethylformamide at a flow rate of 1 ml min-1. Poly(methyl methacrylate) narrow standards (2–
800 kDa, Agilent/Polymer Labs) were used to calibrate the SEC, and sample molecular weights 
and polydispersity indices were calculated using Cirrus 3.0 Software (Polymer Labs).  
 
Dynamic light scattering (DLS): DLS measurements were carried out using a Viscotek 802 
DLS instrument (laser setting λ=830 ± 5 nm). Polymer stock solutions were prepared at 2.0 mg 
ml-1 in PBS and filtered using a Millex HA filter (Merck Millipore). Polyplexes were formed at 
N+/P- or P+/P- ratio 20 by mixing polymer and RNA (final concentration of RNA 0.02 µg µl-1). 
Polyplexes were incubated for 30 minutes at room temperature and analyzed at 20°C. Each sample 
was run in triplicates with 10 runs of 10 seconds duration. Results were analyzed using an 
OmniSIZE software (Viscotek).  
Zeta potential measurements: Zeta potential measurements were performed at N+/P- or P+/P- 
ratio 20 using a Malvern Zetasizer (scattering angle of 173°, 10 mW He-Ne laser), which was 
operated at a wavelength of 633 nm. Polymer stock solutions were prepared at 2.0 mg ml-1 in 
sterile, nuclease-free H2O and filtered using a Millex HA filter. To obtain polyplexes at N
+/P- or 
P+/P- ratio 20, the polymer was complexed with RNA and incubated for 30 minutes at room 
temperature (total volume 200 µl). Prior to zeta potential measurements nuclease-free water was 
added to each sample (800 µL) and injected into a zeta potential cuvette using a syringe. Zeta 
potential readings were performed at 25°C using a Malvern Zetasizer and data was acquired using 
the software (Malvern Zetasizer). 
Gel retardation assay: Polyplexes were prepared at various N+/P- or P+/P- ratios (X = N or P; 
for 0.1:1; 0.5:1; 1:1; 2:1; 4:1; 5:1; 10:1). Polymer stock solutions (2.0 mg ml-1) were prepared in 
PBS and filtered using a Millex HA filter. To form polyplexes equal volumes of RNA and polymer 
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were mixed, immediately vortexed for 30 seconds and incubated at room temperature for 30 
minutes (total volume: 20 µl, containing 266 ng RNA and varying amounts of polymer according 
to the molar ratio). Prior to loading, 3 µl of loading buffer (30% vol/vol glycerol in RNAse free 
H2O) was added to each sample and 20 µl of polyplex solution was loaded onto a 1.5 % w/vol 
TAE agarose gel, and run in 0.5× TAE buffer at 100V for 45 minutes. RNA was visualized with 
ethidium bromide under UV illumination using at 365 nm using a Fujifilm LAS-4000 imager. Gel 
images were processed using ImageJ (National Institutes of Health, http://imagej.nih.gov/ij/)47,48. 
Heparin displacement assay: siRNA polyplexes were prepared at N+/P- or P+/P- ratios of 20 as 
previously described for the gel retardation assay. After 30 minutes incubation at room 
temperature, increasing amounts of heparin (0-2 µg) in PBS (5 µl) were added to 20 µl polyplexes 
and the resulting solutions was incubated for 15 minutes at room temperature. Samples were mixed 
with 4 µl of loading buffer and a sample volume of 15 µl was immediately loaded on a 1.2% 
(w/vol) TAE agarose gel and run at 100V for 30 minutes. RNA was visualized with ethidium 
bromide under UV illumination at 365 nm using a Fujifilm LAS-4000 imager. Gel images were 
processed using ImageJ (National Institutes of Health, http://imagej.nih.gov/ij/)47,48. 
 
Cell culture and maintenance: Cell experiments were carried out with a stable transfected 
green fluorescent protein (GFP) expressing mouse 3T3 cell line and HeLa cells. For confocal 
imaging, a non-transfected 3T3 cell line was employed. Cells were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 2 mM L-glutamine, 1% 
penicillin/streptomycin and 10% foetal calf serum (FCS) under standard culture conditions (37°C, 
5% CO2). For cellular uptake and knockdown studies, cells were cultured in antibiotic-free 
medium (24 hours prior transfection and while performing the experiment) to minimize cell death 
and avoid any potential interaction with RNA-polyplexes. Cellular uptake studies were performed 
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in serum-free medium to avoid RNA degradation which may lead to false-positive signals caused 
by the fluorescent tag diffusing into the cell.     
 
Cell viability (Resazurin assay): Cells were seeded in a 12 well plate at 5x104 cells/well in 
complete growth medium. After 4 hours, polymer solutions (0-1.42 mM), relating to the cationic 
charge; prepared in complete DMEM growth media were added to the cells (1ml polymer solution 
per well). Cells were incubated with polymers for 48 hours followed by a Resazurin assay49,50. For 
the assay, the cell media was removed and cells were washed with PBS. A stock solution of 
Resazurin (diluted 1 in 10 in complete growth media) was added per well (1ml). Cells were 
incubated for 2 hours in the dark and 100 µl of cell supernatant was transferred into a 96-well plate 
to read the fluorescence at 540/590 nm (excitation/emission, Tecan plate reader Infinite 200). For 
data evaluation, the assay background containing media and Resazurin assay reagent were 
subtracted from all assay samples and the fluorescence readings of treated cells were normalized 
to untreated cells and expressed as percentage metabolic activity.   
Resazurin assay reagent (stock solution): Resazurin sodium salt was made up to a concentration 
of 440 μM in phenol red-free HBSS with Ca2+ and Mg2+. Aliquots were stored protected from light 
at -20°C.  
Resazurin assay reagent (for cell viability assay): The Resazurin stock solution was diluted 1 in 
10 in complete growth media and was added directly to the cells. 
siRNA transfection (GFP): 3T3 cells were seeded in antibiotic-free medium in 12-well plates 
and grown overnight (~16-18 hours, cell confluence ~40%). For the preparation of polyplexes, 
siRNA was added to the appropriate polymer solution in PBS (100 µl) and the mixture was 
immediately vortexed (30 seconds) and incubated at room temperature for 30 minutes. In the 
 15 
meantime, cell medium was replaced with 600 µl of serum free medium. Polyplexes were then 
added dropwise to the cells with gentle rocking. GFP knockdown was assessed by flow cytometry. 
Commercially available Interferin (Polyplus transfection) was employed as positive control 
following the manufacturer’s recommendation. 
Cellular uptake studies (confocal and flow cytometry): 3T3 cells were seeded in 12-well 
plates (5x104 cells/well) and were grown in antibiotic-free, complete growth medium overnight. 
For confocal imaging, cells were cultured on sterilized borosilicate cover slips in 12-well plates. 
Polymer-siRNA complexes (N+/P- or P+/P- 20:1) were prepared using Alexa Fluor 647 fluorescent 
labelled siRNA and added to the cells in serum free media (total volume 100 µl). The polyplex 
solutions were then added dropwise to 600 µl DMEM media in each well (final siRNA 
concentration 187 nM). Free, naked siRNA was included as control. Cells were incubated for 4 
hours and relative cellular uptake was assessed by flow cytometry. Subcellular siRNA distribution 
was investigated by confocal microscopy.   
Flow cytometry: 3T3 Cells were transfected with polyplexes (N+/P- or P+/P- ratio 20, 187 nM 
siRNA) in serum free medium and incubated in the dark for 4 hours. After incubation, cells were 
prepared and processed using FACS analysis (FC500, Beckman Coulter, Inc.). A minimum of 
10,000 cells were analyzed for cellular uptake studies. Cell data was analyzed using the Flowing 
Software 2.5 (provided by Cell Imaging Core of the Turku Centre for Biotechnology). For data 
evaluation results were expressed as median fluorescence.  
Confocal imaging: 3T3 cells were seeded onto sterilized borosilicate cover slips and were grown 
in antibiotic-free cell media. Polyplexes (N+/P- or P+/P- ratio 20, 187 nM) were prepared and added 
to the cells. After incubation (4 h), cells were gently washed in PBS (3×), fixed in 4% 
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paraformaldehyde solution for 10 minutes (room temperature), washed in PBS (3×) and stained 
using following staining procedures:  
Wheat germ agglutinin, Alexa Fluor 488 (green): A 5 µg ml-1 working solution was prepared in 
HBSS and added to the cells (500 µl) and incubated for 10 minutes in the dark. Cells were washed 
in HBSS (3×) prior to further processing.  
Hoechst nuclear counterstain: For nuclei counterstaining a 1 µg ml-1 Hoechst solution (33342, 
1,4-diazabicyclo[2.2.2] octane) was prepared in HBSS and added to the cells (500 µl) for 7 minutes 
in the dark. Cells were washed in HBSS (3×) prior to further processing.  
 
The cover slips were gently lifted out of the transwell plate and cells were mounted into 15 µl 
of glycerol solution on a glass slide. The edges of the cover slip were sealed with colourless nail 
vanish and dried for 5 minutes. Samples were stored in the dark at 4°C and analyzed within 3 days. 
Confocal imaging was performed using a confocal laser scanning microscope (Zeiss LSM510 
Meta) equipped with a helium-neon (633 nm) and argon laser (488 nm). The nuclear dye (Hoechst) 
was excited using a mercury lamp. Images were taken at frame size 512 and scan average of 8. Z-
stacks were collected at top and bottom of the cell borders at a size of 1 µm (stack interval) with a 
512 frame size and scan average of 4. Images of at least two fields of view (10 or 40x 
magnification) were collected for every sample. Images were processed using LSM image browser 
(Zeiss) software and ImageJ (National Institutes of Health, http://imagej.nih.gov/ij/)47,48. 
Analysing GFP knockdown using flow cytometry: To analyze siRNA mediated knockdown, 
GFP-3T3 expressing cells were employed. Polyplexes containing siRNA targeting GFP were 
prepared at different N+/P- or P+/P- ratios and added to the cells in serum free media. After 4 hours, 
the medium was changed to antibiotic-free media and cells were incubated for a further 44 hours. 
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For analysis via flow cytometry, cells were washed in PBS (3×) and detached from the plate using 
250 µl trypsin-EDTA for 5 minutes. Antibiotic-free DMEM media (1 ml) was added and cells 
were transferred in 1.5 ml Eppendorf tubes and centrifuged (250× g, 5 minutes). The cell pellet 
was resuspendend in ice-cold FACS buffer (500 µl, 2.5% FBS in 1× PBS) and spun (250× g, 5 
minutes). Finally, the cell pellet was resuspended in 500 µl of FACS buffer and transferred into 
flow cytometry tubes. Cells (n >20,000) were analyzed using a FC 500 instrument (Beckman 
Coulter, Inc.) and Flowing Software 2.5 (Cell Imaging Core of the Turku Centre for 
Biotechnology). For data evaluation, the main cell population was gated to exclude cell debris 
within the side scatter/forward scatter dot plot and was further analyzed. Results were reported as 
median cell fluorescence intensity, normalized to the untreated cell population (cells only).  
 
siRNA transfection (Survivin): HeLa cells were seeded in antibiotic-free medium in 12-well 
plates and were grown overnight (~16-18 hours). Polyplexes of siRNA/liRNA and polymer 4d 
were prepared in PBS at different P+/P- ratio (100 µl) and added to  were added dropwise into each 
well (final volume 1 ml). Cells were incubated for 24 hours and lysed in 500 µl Isol-RNA Lysis 
Reagent (5’ Prime) and processed immediately or stored at -80°C (up to one week). Transfection 
experiments were performed with 30 nM of either siRNA or liRNA. 
Isolation of RNA: To isolate RNA from total cell lysates, which were prepared by the addition 
of lysis buffer (Isol-RNA Lysis Reagent, 5’ Prime), supernatants were transferred into 1.5 ml 
Eppendorf tubes and 100 µl chloroform was added to each sample. Samples were vortexed for 20 
seconds and incubated at room temperature for 10 minutes. The supernatants were then centrifuged 
at 4°C for 25 minutes (16.1× g). The upper aqueous phase was transferred into a new tube and 180 
µl isopropanol were added and samples were mixed for 5 seconds and incubated for further 10 
minutes at room temperature. The tubes were then spun for 20 minute at 4°C (16.1× g). After 
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centrifugation the solution was carefully decanted off and 500 µl of ethanol (75 % vol/vol in 
RNAse free water) were added to the RNA pellet. The pellet was gently flicked and centrifuged 
for 10 minutes at maximum speed at 4°C. The ethanol supernatant was carefully decanted off and 
the pellet was air-dried and resuspended in 12 µl of RNAse-free water and solubilized by 
incubating it at 65°C for 3 minutes. The RNA concentration was determined by spectrophotometry 
using a Nanodrop spectrophotometer (BioSpec Nano, Shimadzu).  
 
Production of cDNA templates for qRT-PCR analysis: RNA was transcribed into 
complementary DNA (cDNA) templates for further analysis using quantitative real-time PCR 
(qRT-PCR). cDNA synthesis was performed using a ImProm-II Reverse Transcription System 
(Promega) according to the manufacturer’s protocol.  
Quantitative reverse transcription real time polymerase chain reaction (qRT-PCR): Target 
gene levels (Survivin and GAPDH) were measured by qRT-PCR using a StepOne real time PCR 
system (Applied Biosystems) as described in the manufacturer’s protocol. Samples were subjected 
to the following qRT-PCR programme:  One cycle of 10 sec at 95°C, 40 cycles of 15 sec at 95°C, 
20 sec at 60°C, 20 sec at 72°C followed by melt curve analysis. For quantification of gene 
expression, a relative quantification method was used to quantify Survivin mRNA levels relative 
to GAPDH expression.  
 
RESULTS AND DICUSSION 
This work focused on synthesizing a family of siRNA-binding polymers where both the nature 
of the permanently charged heteroatom and the length of the chemical spacer linking these cationic 
groups to the polymer backbone were systematically varied. Accordingly, polymers were prepared 
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with either ammonium or phosphonium quaternary salts, and oxyethylene or trioxyethylene 
spacers (Scheme 1). The first step of the synthesis of the required cationic monomers involved the 
conversion of an alkyl halide-alcohol into its corresponding ammonium or phosphonium salt by 
reaction with either triethylamine or triethylphosphine. The halides utilized were 2-bromoethanol 
and 2-[2-(2-bromoethoxy)ethoxy]ethanol leading to their corresponding ammonium or 
phosphonium salts (2a-d).  
 
 
 
Scheme 1. Synthesis of phosphonium- and ammonium-containing methacrylate (3a-d) monomers. 
Reagents and conditions: a. X=N: Et3N, toluene, 75°C, 48 hours; X=P: 1.0 M Et3P in THF, toluene, 
50°C, 48 hours; b. i. methacryloyl chloride Et3N, dichloromethane; ii. brine; c. i. V501, 4-cyano-
4-thiobenzoylthio)pentanoic acid (CTB, CTA), EtOH:D2O 3:1, 70°C. [M]0:[CTA]0:[I]0= 
100:1:0.5; ii. AIBN (20 eq.), DMSO, 80°C, 3 hours. DPtheo was calculated based on conversion at 
which the polymerization was stopped. Mn and PDi as measured by SEC in 0.5% NH4BF4 (w/v) 
in DMF as the mobile phase.   
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The alcohols (2a-d) were then treated with methacryloyl chloride and triethylamine in CH2Cl2 
followed by counterion exchange with brine and flash chromatography, to give the required 
monomers (3a-d). The monomers were polymerized using aqueous RAFT polymerization giving 
a library with different length of the linker connecting the cationic moieties to the polymer 
backbone and nature of the heteroatom salts (ammonium or phosphonium).  
Reversible Addition-Fragmentation chain Transfer (RAFT) polymerization of monomers (4a-d) 
was carried out using 4-cyano-4-thiobenzoylthio)pentanoic acid (CTB) as the chain transfer agent 
(CTA), V-501 as radical initiator using a molar ratio of [M]0: [CTA]0: [I]0 = 100: 0.5: 1 in 
D2O/EtOH (3:1 vol/vol) as solvent at 70°C. Deuterated solvent was used in the polymerization to 
facilitate monomer conversion monitoring by 1H NMR. Polymerizations were controlled, as 
demonstrated by substantially linear first-order kinetics. In some cases an initial induction time, 
typical of RAFT polymerization51,52 was observed (see supporting information). The polymers 
were precipitated in Et2O or THF to remove unreacted monomers and low molecular weight 
impurities. Then, the dithioester CTA moieties at the end of the polymer chains were removed 
following the Perrier method53. All polymers were found to be water-soluble, with low 
polydispersity indices (PDiSEC: 1.10-1.15). 
siRNA complexation studies. The ability of polymers (4a-d) to bind siRNA was first assessed 
in a gel retardation assay to estimate the amount of polymer required to quantitatively bind RNA. 
Polymers were complexed with siRNA at different N+/P- or P+/P- ratios (0.1, 0.5, 1, 2, 4, 5, 10) - 
the molar ratio between the positively charged polymer repeating units, and the anionic phosphate 
groups on siRNA After incubation of 30 minutes at room temperature, products were analysed by 
agarose gel electrophoresis. All polymers were found to quantitatively bind siRNA at N+/P- or 
P+/P- ratio between 1 and 2 (2 being the first ratio where no free siRNA was detected) (Figure 1A). 
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Semi-quantitative analysis was carried out by fitting the data to a modified Hill’s equation, which 
suggested that phosphonium-based polymers bound siRNA slightly better than corresponding 
ammonium analogues (K4a = 0.62 ± 0.04 vs. K4b =0.43 ± 0.05) for polymers with shorter linker 
and longer linker (K4c =0.39 ± 0.08 and K4d =0.28 ± 0.06) (Figure 1B, Table 1). K values reflect 
the amount of polymer required to complex 50% of the siRNA in the incubation samples, thus the 
polymers with better ability to complex siRNA possess the lowest K. Furthermore, the length of 
the oxyethylene linker seemed to influence polymer binding, with better binding observed for 
polymers containing the longer linker (4a vs. 4c, and 4b vs. 4d). These results are in agreement 
with previous reports  which demonstrated better binding for phosphonium based polymers over 
their corresponding ammonium analogues, 38,39 although for the systems investigated in this 
present work the observed difference was relatively modest.  
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Figure 1: A) Gel retardation assay with siRNA and polymers (4a-d). Polyplexes were formed at 
different N+/P- or P+/P- ratios. Samples were incubated for 30 minutes at room temperature before 
loading onto a 1.5% w/vol agarose gel (100V, 45 minutes). Representative gel images are shown, 
from three independent experiments. B) Estimation of polymer/RNA binding by fitting data into 
a modified Hill’s equation. Data was plotted as complexed RNA at different polymer 
concentrations (µg/ml), expressed here as N+/P- or P+/P- ratio. 
 
Table 1: Hill’s equation’s binding constant K, representing half-maximum binding at 30 minutes 
for siRNA polyplexes. K is expressed as polymer concentration (µg/ml) N+/P- or P+/P- ratio. Data 
represents best-fit values ± SD.  
Polymer Atom  K (µg/ml) K (N+/P- or P+/P- ratio) 
4a N 12.8 ± 0.8 0.62 ± 0.04 
4b P 9.4 ± 1.2 0.43 ± 0.05 
4c N 10.8 ± 2.2 0.39  ± 0.08 
4d P 8.2 ± 1.6 0.28  ± 0.06 
 
 
 
The ability of polymers to retain siRNA upon complex formation in the presence of competitive 
polyanionic ligands was analyzed in a heparin displacement assay. Polyplexes were formed at 
N+/P- or P+/P- ratio of 20 and increasing amounts of heparin sodium salt were added and the 
incubation mixtures analyzed by agarose gel electrophoresis (Figure 2). For polymers with the 
short oxyethylene spacer (4a, 4b), RNA displacement occurred following addition of 0.7-1.0 µg 
heparin with the ammonium polymer 4a showing a slightly better tendency to bind RNA than its 
phosphonium analogue 4b. In contrast, complexes formed with polymers with the longer 
 23 
trioxyethylene linker, 4c and 4d, were more stable, with RNA displaced by the addition of 1.0-1.3 
and 1.3-1.7 µg heparin, respectively. These results indicate that polyplexes formed with polymers 
with the longer linker had higher stability in the presence of heparin than their corresponding 
analogues. In addition, polyplexes formed with phosphonium polymer 4d were found to be more 
stable under these conditions than its ammonium analogue 4c suggesting an effect of the nature of 
the charged heteroatom on the stability of the resulting polycomplex. This behaviour could be 
ascribed to a different charge distribution within the alkylphosphonium cation, together with larger 
cationic size which potentially favours nucleic acid binding with phosphonium-based polymers as 
the positive charge is more localised on the heteroatom and less diffused in comparison to 
ammonium based polymers38,39. In addition, the binding and stability results indicate that polymers 
with longer trioxyethylene linker have improved binding with nucleic acids, possibly due to 
enhanced macromolecular flexibility which allow them to rearrange their chain conformation 
around the RNA molecules, achieving more efficient binding.  
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Figure 2: Heparin displacement assay. Polyplexes of N+/P- or P+/P- 20 were prepared and 
incubated for 30 minutes at room temperature. Increasing concentrations of heparin were added 
and samples were incubated for 15 minutes prior to analysis by 1.2% agarose gel electrophoresis 
(100V, 30 minutes). A representative image of each experiment is shown. 
 
Efficient cell uptake of polyplexes is highly dependent on their size and net charge. For DLS 
and zeta potential studies N+/P- or P+/P- ratios of 20 were chosen, as preliminary experiments using 
agarose gel electrophoresis confirmed efficient binding of nucleic acid under these conditions. 
This would also likely result in a proportion of unbound polymer chains in the polyplex 
formulations, which in some cases has been shown to be beneficial for improved gene knockdown 
and/or transfection in vitro54,55. While DLS measurements can be presented as intensity 
distribution results may be misleading, when studying a heterogeneous sample population, in 
which larger particles can dominate the sample due to an increase in light scattering56,57. To give 
an overview of the actual mass distribution with the sample population, the intensity distribution 
can be converted into mass by employing a mathematical model using the Mie theory56,57. While 
polymers (4a-d), RNA polyplexes ranged from ~ 4-15 nm in radius with polymer 4d forming the 
smallest RNA polyplex (~4 nm) and polymer 4c the largest (~15 nm). For RNA polyplexes formed 
with polymers 4a-c, traces corresponding to larger aggregates were also detected (Figure 3 and 
Supplementary data). The zeta potential at N+/P- or P+/P- ratios 20 in aqueous medium showed a 
net positive surface charge for all polyplexes (~ +24-31 mV).  
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Polyplexes Rh (nm) Zeta- potential (mV)  
siRNA 1.02 ± 0.07 −21.9 ± 5.3 
4a 8.8 ± 2.2 30.1 ±  6.9 
4b 13.7 ± 5.6 24 ±  2.8 
4c 14.8 ± 6.9 30.5 ±  3.7 
4d 4 ± 1 31.3 ±  3.4 
 
Figure 3: Dynamic light scattering and zeta potential measurement of RNA polyplexes at N+/P- 
or P+/P- ratio 20. A) For DLS measurements polyplexes were prepared in PBS using a final 
concentration of 0.02 µg µl-1 RNA in each sample. The table gives an overview of results for DLS 
and zeta potential measurements for RNA polyplexes (main population) at N+/P- or P+/P- ratio of 
20.  
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The effect of polymers (4a-d) on the cell viability was evaluated using a Resazurin metabolic 
cell assay49 (Figure 4). Metabolically active and hence viable cells convert Resazurin substrate 
into fluorescent Resorfurin, the amount of which is directly proportional to the cell number of 
viable cells (provided they are within the linear range of the detection)50. Fibroblast 3T3 cells were 
exposed to increasing polymer concentrations (0-1.4 mM of cationic repeating units) for 48 hours. 
The results indicated good cell viabilities (≥75%) for all polymers up to concentrations of 0.42 
mM (which is above the polymer concentration utilized in subsequent cell studies), whilst a 
reduction of metabolic activity was found when using concentrations ≥ 0.56 mM (4a-d) which 
corresponds to 140-200 µg ml-1, depending on the polymer investigated. In contrast, PEI 
(branched, 25kDa), a polymer commonly utilized for DNA/RNA complexation, showed a high 
cytotoxicity at all concentrations (6-60 µg ml-1) investigated.  
  
 
Figure 4: Cell viability assay following polymer exposure. Cells (mouse 3T3) were exposed 
increasing polymer concentrations. Cell viability was assessed using a resazurin assay after 48 
hours exposure. Branched poly(ethylene imine) (25 kDa, bPEI) was used as a control. Error bars 
indicate the standard error of the mean (n=3).  
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Poly(meth)acrylates have been widely investigated for biomedical applications58,59. Clinically 
they are routinely utilized as biocompatible and biodurable materials in a range of applications 
which include intraocular lenses60, orthopedic implant fixation61, dentistry62, and the manufactory 
of drug-eluting coronary stents63. This part of the present study suggests that these phosphonium-
based materials are not cytotoxic at concentrations suitable for RNAi in vitro, although further in 
vivo studies will be needed to investigate their pharmacokinetic profiles and long-term 
biocompatibility. 
The ability of polyplexes to mediate RNA uptake by 3T3 cells was investigated by flow 
cytometry and confocal microscopy. Polyplexes were formed with Alexa Fluor 647-conjugated 
siRNA (187 nM final concentration per sample) at N+/P- or P+/P- ratios of 20, and incubated with 
the cells for 4 hours. In flow cytometry measurements a strong increase of fluorescence was 
observed for all polyplexes in comparison to naked RNA (Figure 5A/B). Higher fluorescence was 
observed for polymers with the shorter linker (4a-b) in comparison to polymers with the longer 
trioxyethylene spacer. To investigate whether the observed fluorescence resulted from cell surface-
bound fluorescent species or cellular uptake of polyplexes, confocal imaging was performed 
(Figure 5 C/D). Quantitative analysis of confocal images confirmed the internalization of 
polyplexes (≥75%). 
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Figure 5: Cellular uptake of Alexa Fluor 647-conjugated RNA polyplexes (4a-d) by 3T3 cells: 
flow cytometry (A/B) and confocal imaging (C/D). A) For flow cytometry 2×104 3T3-GFP cells 
were analyzed, and results were normalized to the median fluorescence intensity of untreated cells. 
Data is represented as median fluorescence, error bars indicate the standard error of the mean 
(n=3). B) Representative histogram overlays of RNA (negative control) and polyplexes (4a-d) C) 
For confocal laser scanning microscopy 3T3 cells were cultured on borosilicate glass slides (12-
well plates) and uptake was analyzed after 4 hours exposure. Cellular uptake of RNA-polyplexes 
can be observed by the internalization of RNA (red fluorescence) within in the cell. Cell plasma 
membrane is stained in green and the cell nucleus stained in blue. Representative images shown, 
scale bar: 25 µm D) Quantitative analysis of siRNA uptake (%) as analyzed by confocal imaging. 
A minimum of three representative images containing 45-60 cells in total) of three different 
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experiments were analyzed. SiRNA uptake represents the percentage of cells with internalized 
siRNA. Error bars indicate the standard error of the mean (n=3). 
 
Whilst flow cytometry and confocal microscopy showed good cellular uptake for all polyplexes, 
all polymers (4a-d) investigated failed to mediate siRNA knockdown when targeting GFP in GFP-
expressing 3T3 cells as analyzed flow cytometry. In contrast, commercially available Interferin 
successfully reduced GFP fluorescence by 71% in comparison to untreated cells (see 
supplementary data). Polyplexes were incubated for 48 hours at N+/P- or P+/P- ratio 5 or 20 using 
187 nM total siRNA per sample. Recent studies by Reineke54 and Yue55 suggested that an excess 
of polymer within a polymer formulation increases cellular knockdown. For both N+/P- or P+/P- 
ratios (5 and 20) investigated here, good RNA binding was achieved as demonstrated by a gel 
retardation assay (Figure 1). In parallel to knockdown experiments, cell viability studies were 
performed to evaluate if the RNA polyplexes (at a N+/P- or P+/P- ratio 20 and/or 5) display cellular 
toxicity when incubated with cells in vitro (48 hours). The results indicated that treatment with 
RNA formulations at experimental conditions employed for transfection experiments did not affect 
cell metabolic activity, highlighting the non-toxic nature of polymers and deriving polyplex 
formulations, under the range of concentrations investigated (see supplementary data). 
Taken together these experiments showed that although polymers (4a-d) mediated efficient 
RNA uptake in 3T3 cells while being non-toxic, they were unable to promote detectable levels of 
mRNA knockdown. One possible explanation is that their RNA polyplexes may not undergo 
efficient endosomal escape, and eventually be degraded in lysosomes. This could be ascribed to 
the polymers possessing permanently charged moieties unable to promote endosomal escape 
routes like “proton sponge” effects64. However, gene knockdown mediated by permanently 
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charged polymers with no endosomolytic moieties has been reported38,65,66, which prompted us to 
further vary additional structural parameters in the polyplexes – i.e. the macromolecular 
architecture of the RNA payload - and investigate its effect of gene knockdown efficiency.  
 
Effect of RNA molecular architecture on gene knockdown. Recently, multimeric RNAs with 
well-defined macromolecular architectures - tripodal, cross-shaped, and linear long interfering 
siRNA – have emerged as efficient tools to enhance gene delivery and knockdown efficiency67,68. 
These novel RNA multimers were found to particularly efficient in mediating RNAi, due to both 
enhanced ability to complex various cationic non-viral delivery vectors, and increased RNA cell 
uptake, compared to relatively small and stiff siRNA. In a recent study by Sajeesh et al. long 
interfering RNA has been used to form nanocomplexes with cationic polymer systems such as 
branched PEI (25 kDa) and linear PEI (25 kDa)69. Improved ability to form polyplexes at lower 
N+/P- ratio was observed for liRNA formulations compared to those where “conventional” shorter 
siRNA was employed as analyzed by DLS and AFM. Polyplexes with liRNA were also found to 
be more stable in the presence of competitive polyanionic ligands, as revealed by heparin 
displacement assay. A reduction of Survivin mRNA expression to ~20% using branched PEI at 
N+/P- ratio of 5 with 30 nM liRNA was achieved, as revealed by qRT-PCR analysis. In contrast, 
no knockdown was achieved using various PEI-siRNA under otherwise identical experimental 
conditions. In this present work we aimed at investigating the effect of RNA architecture on gene 
knockdown, utilising one of our phosphonium polymethacrylates polymers. For this part of our 
study, polymer 4d was selected to generate polyplexes with liRNA targeting Survivin. To generate 
liRNA, the RNA sequence was designed in a way that annealing of complementary sense and 
 31 
antisense strands leads to a long overhang which enables the addition of a further RNA strand 
creating a new long overhang (Figure 6A).  
Pleasingly, 4d-liRNA polyplexes mediated efficient mRNA knockdown of Survivin in HeLa 
cells (~65 %) when employing a P+/P- ratio of 10, using 30 nM liRNA (Figure 6B). Interestingly, 
lower knockdown of Survivin was observed when using a higher P+/P- ratio of 20, confirming that 
the engineering of the formulation for a given polymer/RNA system is an important parameter 
which should be considered in formulation design. In contrast, no significant knockdown was 
observed for shorter conventional siRNA targeting Survivin expression, revealing that for this 
specific polycationic polymer/RNA system, multimeric siRNAs was a superior agents for RNAi. 
(Please note that successful knockdown of Survivin using siSurvivn and commercially transfection 
agents was previously demonstrated69–71). The effect of polymer (4d) on the cell viability was 
assessed using a Resazurin metabolic cell assay49 (Figure 6C). HeLa cells were exposed to 
increasing polymer concentrations (0-1.4 mM of cationic repeating units) for 48 hours. In 
agreement with results obtained using mouse 3T3 cells (Figure 4), the results indicated good cell 
viabilities (≥75%) up to concentrations of 0.56 mM and above, making polymer 4d a suitable 
delivery vectors for cellular in vitro studies.  
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Figure 6: A) Structure of liRNA targeting Survivin. Please note that the last 19 nucleotides of the 
5’3 antisense strand (red) are complementary to the first 19 nucleotides of the 3’5 sense strand 
(red). In addition, the first 19 nucleotides of the 5’3 antisense strand (black) are complementary to 
the last 19 nucleotides of the 3’5 sense strand (black). The specific RNA design enables 
multimerization due to a long overhang which enables the addition of a further RNA strand 
creating a new overhang. B) Knockdown studies with siRNA and liRNA targeting Survivin. HeLa 
cells were transfected with polymer 4d using a P+/P- ratio of 10 and 20, with 30 nM siRNA or 
liRNA targeting Survivin. Survivin and GAPDH mRNA levels were measured by qRT-PCR 24 
hours after transfection. Relative mRNA levels were determined by comparison of cells treated 
with siRNA/liRNA targeting Survivin and non-targeting control siRNA/liRNA. Data is 
represented as relative mRNA level (%) mean ± SEM and was analyzed by one-way ANOVA 
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followed by Turkey’s multiple comparison, (**p ≤ 0.01) C) Resazurin cell viability assay for 
polymer 4d in HeLa cells (n=3). 
 
CONCLUSIONS 
In this work we present an efficient route for the synthesis of phosphonium-containing polymers, 
an emerging class of materials for nucleic acid binding and delivery. By using aqueous RAFT 
polymerization, a family of well-defined cationic polymethacrylates with with low polydispersity 
(PDiSEC = 1.1-1.15) were prepared. Both the nature of the charged heteroatom – P vs. N – and 
length of the spacer connecting the cationic moieties to the polymer backbone –oxyethylene vs. 
trioxyethylene– were systematically varied. Both parameters were found to affect the ability of 
polymers to bind siRNA. Phosphonium-based polymers showed marginally better siRNA binding 
(at lower P+/P- ratio) than their corresponding ammonium analogues as estimated by Hill’s 
analysis. In addition, polymers with a longer trioxyethylene spacer between the charged 
heteroatoms and the polymer backbone showed better siRNA binding than those containing a 
shorter oxyethylene linker, possibly due to increased polymer flexibility, which would allow a 
more efficient rearrangement of the cationic repeating units to bind the phosphate groups of the 
relatively rigid rod-like siRNA molecules.  
Although RNA polyplexes with polymers (4a-d) were all efficiently internalized by GFP-
expressing 3T3 cells, no detectable siRNA-mediated GFP knockdown was observed. While further 
work will be needed to better understand this phenomenon, one likely explanation could be poor 
polyplex endosomolytic escape, although other experimental design factors, such as the choice of 
cell line and experimental conditions chosen for the knockdown studies may also play an important 
role.  
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By contrast, using phosphonium polymer 4d, efficient Survivin mRNA knockdown was 
observed in HeLa cells when siRNA was replaced with multimerised liRNA demonstrating a 
strong effect of RNA structure on the efficiency of RNA interference. Future work will focus on 
how additional macromolecular features of both polymer – chain length and macromolecular 
architecture (e. g. linear vs. star), and RNA - RNA multimers such as liRNA, tripodal and 
quadruple interfering RNA69,72,73 – affect intracellular trafficking and mRNA knockdown.  
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